PRESS RELEASE published on 02/18/2026 at 15:40, 6 months 27 days ago Form 8.3 - The Vanguard Group, Inc.: JTC PLC The Vanguard Group, Inc. discloses a 5.07% stake in JTC PLC through Form 8.3 filing as of 17 February 2026 Form 8.3 Vanguard Group Financial Disclosure Stake Disclosure JTC Plc
PRESS RELEASE published on 02/18/2026 at 15:37, 6 months 27 days ago Form 8.3 - The Vanguard Group, Inc.: Beazley PLC The Vanguard Group, Inc. discloses a 5.03% stake in Beazley PLC as of 17-Feb-2026. Details of securities holdings and recent dealings outlined in Form 8.3 Securities Form 8.3 The Vanguard Group Dealings Beazley Plc
BRIEF published on 02/16/2026 at 15:35, 7 months 1 day ago Vanguard Discloses Stake in JTC plc Under Takeover Code Form 8.3 Takeover Code Securities Disclosure Vanguard Group JTC Plc
BRIEF published on 02/16/2026 at 15:35, 7 months 1 day ago Vanguard Group Discloses Position in Bluefield Solar Income Fund Form 8.3 Takeover Code Securities Disclosure Vanguard Group Bluefield Solar
BRIEF published on 02/16/2026 at 15:34, 7 months 1 day ago The Vanguard Group Postions on Beazley plc Shares Rule 8.3 Securities Disclosure Vanguard Group Share Transactions Beazley Plc
BRIEF published on 02/16/2026 at 15:33, 7 months 1 day ago Vanguard's Investment Position in Schroders plc Takeover Code Securities Disclosure Schroders Plc Vanguard Group Share Transactions
BRIEF published on 02/16/2026 at 15:32, 7 months 1 day ago The Vanguard Group Discloses Position in Spire Healthcare The Vanguard Group Takeover Code Securities Disclosure Spire Healthcare Share Transactions
BRIEF published on 02/16/2026 at 15:32, 7 months 1 day ago The Vanguard Group Discloses Position in Oxford Biomedica Form 8.3 Takeover Code Securities Disclosure Vanguard Group Oxford Biomedica
PRESS RELEASE published on 02/16/2026 at 15:30, 7 months 1 day ago Form 8.3 - The Vanguard Group, Inc.: JTC plc The Vanguard Group, Inc. discloses holding 5.07% in JTC plc. Form 8.3 filing under Rule 8.3 of Takeover Code. Transaction details of 1p ordinary shares included The Vanguard Group, Inc. Form 8.3 Takeover Code 1p Ordinary Shares JTC Plc
BRIEF published on 02/16/2026 at 15:30, 7 months 1 day ago The Vanguard Group Reports Significant Stake in Just Group plc Securities Disclosure Vanguard Group Inc. Shareholding Just Group Plc
Published on 09/18/2026 at 06:30, 6 hours 16 minutes ago GREE Chairperson Dong Mingzhu Honored by UNEP Cool Coalition for Leadership in Sustainable Cooling
Published on 09/18/2026 at 00:55, 11 hours 51 minutes ago Tectonic Metals Announces Results of the 2026 Annual General Meeting
Published on 09/18/2026 at 00:25, 12 hours 21 minutes ago CoTec Holdings Corp. Announces Initial Closing of Private Placement of Unsecured Convertible Debentures
Published on 09/17/2026 at 22:15, 14 hours 31 minutes ago Rocky Shore Gold Announces Non-Brokered Private Placement
Published on 09/18/2026 at 12:35, 11 minutes ago mAbxience and Sandoz Sign a Collaboration Agreement to Advance Biosimilar Access Worldwide
Published on 09/18/2026 at 12:32, 14 minutes ago EQS-Adhoc: Wolford AG: Mandate of Ralf Polito as Member of the Management Board extended
Published on 09/18/2026 at 12:00, 46 minutes ago BIRKENSTOCK OPENS A NEW STORE IN THE HEART OF BERLIN
Published on 09/18/2026 at 12:00, 46 minutes ago Warren Wise scans Siemens Healthineers: Sharp images for doctors, blurry ones for investors
Published on 09/18/2026 at 11:55, 51 minutes ago Xryma Plc Reports Steady H1 2026 Results While Positioning the Group for Its Next Phase of Growth
Published on 09/17/2026 at 17:40, 19 hours 6 minutes ago Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany
Published on 09/16/2026 at 17:45, 1 day 19 hours ago Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 2 days 5 hours ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
